WMT-N -2.5 MSFT-Q -9.03 CBOE-Q 1.32 AMZN-Q -17.6 COST-Q 2 TLT-Q 0.42 PHYS-T -0.76 ARE-T -0.31
Home Daily Stock Opinions and Ratings Hemosol (HML-T)

Hemosol (HML-T)

NEW AI Investor Insights
0 watching

0.00
0.00 (0.00%) 1d
0
DON'T BUY

Hemosol(HML-T)

Aug 09, 2005
This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
Bill CarriganBill Carrigan
Unknown
Unlock Rating
$1.500

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Jun 13, 2005
Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
Peter HodsonPeter Hodson
No
Unlock Rating
$1.750

Stock price when the opinion was issued

biotechnology pharmaceutical
TRADE

Hemosol(HML-T)

Feb 09, 2004
Speculative future.
Michael SprungMichael Sprung
Unknown
Unlock Rating
$1.580

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Hemosol(HML-T)

Jan 28, 2004
It will expire again, company has run out of money many times. Take money out, while money is on the table.
Andrew McCreathAndrew McCreath
Unknown
Unlock Rating
$1.620

Stock price when the opinion was issued

biotechnology pharmaceutical
SELL

Hemosol(HML-T)

Jan 26, 2004
Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
Andrew McCreathAndrew McCreath
No
Unlock Rating
$1.560

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Dec 15, 2003
Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
Gavin GrahamGavin Graham
No
Unlock Rating
$1.580

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Dec 08, 2003
Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
Robert FloydRobert Floyd
No
Unlock Rating
$1.700

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Dec 08, 2003
A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
John Sinkins, CFAJohn Sinkins, CFA
Unknown
Unlock Rating
$1.700

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Sep 05, 2003
Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
Lou SchizasLou Schizas
Unknown
Unlock Rating
$0.870

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Mar 31, 2003
Very speculative. FDA trials didn't go well.
John Sinkins, CFAJohn Sinkins, CFA
Unknown
Unlock Rating
$0.720

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Mar 17, 2003
A lot of problems. May not survive.
Glenn Paradis, BA, CFAGlenn Paradis, BA, CFA
Unknown
Unlock Rating
$0.620

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Jan 14, 2003
A long way from being a mature company with mature products. Speculative.
David BaskinDavid Baskin
Unknown
Unlock Rating
$2.890

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Jan 14, 2003
Never seems to get it together.
Michael SmedleyMichael Smedley
Unknown
Unlock Rating
$2.890

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Hemosol(HML-T)

Dec 05, 2002
Worst is behind them. Would prefer owning through MDS.
John ZechnerJohn Zechner
Unknown
Unlock Rating
$2.500

Stock price when the opinion was issued

biotechnology pharmaceutical
WEAK BUY

Hemosol(HML-T)

Nov 07, 2002
OK for a long term hold. Buy on weakness.
Bruce Campbell (1)Bruce Campbell (1)
Unknown
Unlock Rating
$1.900

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 15 of 78 entries
Next PageNext Page

Hemosol(HML-T) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Hemosol is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Hemosol(HML-T) Frequently Asked Questions

What is Hemosol stock symbol?

Hemosol is a OTC stock, trading under the symbol HML-T on the (). It is usually referred to as or HML-T

Is Hemosol a buy or a sell?

In the last year, there was no coverage of Hemosol published on Stockchase.

Is Hemosol a good investment or a top pick?

Hemosol was recommended as a Top Pick by on . Read the latest stock experts ratings for Hemosol.

Why is Hemosol stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Hemosol worth watching?

In the last year 0 stock analysts on Stockchase covered Hemosol. The stock is worth watching.

What is Hemosol stock price?

On , Hemosol (HML-T) stock closed at a price of $.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

HY-NHyster-Yale Materials Handling, Inc.
Hyster-Yale Materials Handling, Inc.
$37.04
-5.00 (-15.61%)
GCT-QGigaCloud Technology Inc.
GigaCloud Technology Inc.
$13.77
-0.96 (-7.49%)
F-NFord Motor
Ford Motor
$9.54
-0.61 (-6.83%)
BSX-NBoston Scientific Corp
Boston Scientific Corp
$98.50
-1.55 (-1.60%)
CNQ-TCanadian Natural Rsrcs
Canadian Natural Rsrcs
$42.05
-3.01 (-7.71%)
Advertising

Today's Top Picks

CASH-TGlobal X High Interest Savings ETF
Global X High Interest Savings ETF
$50.00
0.00 (0.00%)
CASH-THorizons High Interest Savings ETF
Horizons High Interest Savings ETF
$50.00
0.00 (0.00%)
PHYS-TSprott Physical Gold
Sprott Physical Gold
$33.91
-0.76 (-2.29%)
TLT-QiShares 20+ Year Treasury Bond ETF
iShares 20+ Year Treasury Bond ETF
$91.85
0.42 (0.46%)
COST-QCostco Wholesale Corporation
Costco Wholesale Corporation
$967.08
2.00 (0.21%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

CLS-TCelestica Inc
Celestica Inc
$97.27
-20.66 (-26.97%)
IBM-NIBM Common Stock
IBM Common Stock
$243.49
-6.49 (-2.74%)
VRT-NVertiv Holdings
Vertiv Holdings
$67.47
-9.64 (-16.67%)
OKLO-NOklo
Oklo
$21.89
-0.81 (-3.84%)
LUV-NSouthwest Airlines
Southwest Airlines
$28.86
-3.00 (-11.60%)

Most Recent Experts

Caldwell

Brendan Caldwell

Caldwell Securities

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase

Stockchase Insights

5i Research

Cramer

Jim Cramer - Mad Money

CNBC

Advertising
Advertising
© Stockchase Inc.